US Patent 8029782 Therapeutic ribonucleases
Patent 8029782 was granted and assigned to Quintessence Biosciences on October, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 1, 2009
Date of Patent
October 4, 2011
Patent Application Number
12572016
Patent Inventor Names
Laura Strong
0
John Kink
0
Tony Klink
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8029782 Therapeutic ribonucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.